Anita H. Clayton, MD

home / authors / anita-h-clayton-md

Articles

Early Improvement of Symptoms in Bipolar 1 Depression

May 30th 2024

Anita H. Clayton, MD, gives a preview of her upcoming poster presentation at the 2024 ASCP Annual Meeting.

Exciting Possibilities at ASCP 2024

Anita H. Clayton, MD

May 29th 2024

Anita H. Clayton, MD, welcomes us all to the 2024 ASCP Annual Meeting!

Postpartum depression and major depressive disorder in pregnant and postpartum women are severely underdiagnosed and undertreated. How can we more effectively help this patient population?

Promising New Treatments for Postpartum Depression

Anita H. Clayton, MD;Nathan Bryson, PhD

November 23rd 2022

Postpartum depression and major depressive disorder in pregnant and postpartum women are severely underdiagnosed and undertreated. How can we more effectively help this patient population?

Evaluating Every Patient

Anita H. Clayton, MD

April 26th 2022

Sex and gender, influenced by genetics, epigenetics, and environmental/social stressors, must be considerations in evaluating every patient.

More Than Postpartum Depression: Addressing Maternal Mental Health Through the Life Cycle

Anita H. Clayton, MD

May 11th 2021

What are the implications of maternal mental health not only for mothers, but also for children, families, and society as a whole?

Flibanserin: More Than Just a “Pink Viagra”

Anita H. Clayton, MD

October 1st 2015

Flibanserin is a breakthrough. We will finally be able to talk to women with hypoactive sexual desire disorder about a treatment that has FDA approval.